Drug Chatter -- Tracking biopharma stock chatter

💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch

Profile for Exelixis, Inc. (EXEL)

« Back to company index

EXEL Chatter Timeline

Stock Ticker for EXEL

Most Active Tweeters for EXEL

UserTweets
@FlashAlert_me 14
@InsiderAlerts4U 12
@Tickeron 8
@StockAlarms 6
@TradeWithAlerts 5

Recent Tweets for EXEL

Xemadeyaka14 @Xemadeyaka14
RT @ExelixisInc: Positive results from studies of $EXEL flagship therapy and @Roche #immunotherapy in #BladderCancer and #LungCancer just a…
May 28th 2022, 11:05am
Xemadeyaka14 @Xemadeyaka14
RT @ExelixisInc: Data from $EXEL flagship therapy in combination with an #immunotherapy in #HeadAndNeckCancer presented at #ASCO22. Learn m…
May 28th 2022, 11:05am
Tickeron @Tickeron
$EXEL's 10-day Moving Average crossed below its 50-day Moving Average on May 10, 2022. View odds for this and other… https://t.co/L4k4D1zEVx
May 28th 2022, 8:05am
QuantchaIdeas @QuantchaIdeas
StockTwits Trending Alert: Trading recent interest in EXELIXIS $EXEL https://t.co/upbWIMg1Qa
May 28th 2022, 5:05am
Tickeron @Tickeron
$EXEL enters a Downtrend because Momentum Indicator dropped below the 0 level on April 28, 2022. View odds for this… https://t.co/qkmzjr4fiI
May 28th 2022, 3:05am
Tickeron @Tickeron
How does this make you feel? $EXEL RSI Indicator left the oversold zone. #Exelixis #stockmarket #stock… https://t.co/xASAThEyTZ
May 28th 2022, 2:05am
InsiderAlerts4U @InsiderAlerts4U
$EXEL: New Insider Filing on EXELIXIS, INC.'s Director GEORGE POSTE: https://t.co/kZ4jrtwUnS
May 28th 2022, 1:05am
InsiderAlerts4U @InsiderAlerts4U
$EXEL: New Insider Filing on EXELIXIS, INC.'s Director VINCENT T MARCHESI: https://t.co/F6ei9WHgic
May 28th 2022, 1:05am
InsiderAlerts4U @InsiderAlerts4U
$EXEL: New Insider Filing on EXELIXIS, INC.'s Director STELIOS PAPADOPOULOS: https://t.co/Pi82Nja6p3
May 28th 2022, 1:05am
FlashAlert_me @FlashAlert_me
$EXEL [15s. delayed] filed SEC form 4: Director POSTE GEORGE: Granted 19,575 of Common Stock at price $0 on 2022-0… https://t.co/5hE0veTj33
May 28th 2022, 1:05am
FlashAlert_me @FlashAlert_me
$EXEL [15s. delayed] filed SEC form 4: Director PAPADOPOULOS STELIOS: Granted 19,575 of Common Stock at price $0 o… https://t.co/yHggQNskuv
May 28th 2022, 1:05am
InsiderAlerts4U @InsiderAlerts4U
$EXEL: New Insider Filing on EXELIXIS, INC.'s Director JACQUELINE WRIGHT: https://t.co/R8dwt9SimV
May 28th 2022, 1:05am
FlashAlert_me @FlashAlert_me
$EXEL [15s. delayed] filed SEC form 4: Director MARCHESI VINCENT T: Granted 19,575 of Common Stock at price $0 on… https://t.co/ml6nI38YDc
May 28th 2022, 1:05am
FlashAlert_me @FlashAlert_me
$EXEL [15s. delayed] filed SEC form 4: Director Smith Julie: Transacted Derivative Securities on 2022-05-26. https://t.co/aQAkz7d8lZ
May 28th 2022, 1:05am
FlashAlert_me @FlashAlert_me
$EXEL [15s. delayed] filed SEC form 4: Director Wright Jacqueline: Granted 10,180 of Common Stock at price $0 on 2… https://t.co/aJNaSRdZLC
May 28th 2022, 1:05am
InsiderAlerts4U @InsiderAlerts4U
$EXEL: New Insider Filing on EXELIXIS, INC.'s Director MARIA C FREIRE: https://t.co/Rk05NjyjGE
May 28th 2022, 12:05am
InsiderAlerts4U @InsiderAlerts4U
$EXEL: New Insider Filing on EXELIXIS, INC.'s Director LANCE WILLSEY: https://t.co/x3tvVh9CvT
May 28th 2022, 12:05am
FlashAlert_me @FlashAlert_me
$EXEL [15s. delayed] filed SEC form 4: Director WILLSEY LANCE: Transacted Derivative Securities on 2022-05-26. https://t.co/41tPZKe2oP
May 28th 2022, 12:05am
InsiderAlerts4U @InsiderAlerts4U
$EXEL: New Insider Filing on EXELIXIS, INC.'s Director ALAN M GARBER: https://t.co/WKCf02AXDg
May 28th 2022, 12:05am
InsiderAlerts4U @InsiderAlerts4U
$EXEL: New Insider Filing on EXELIXIS, INC.'s Director CARL B FELDBAUM: https://t.co/4ryvs7Mtsm
May 28th 2022, 12:05am
FlashAlert_me @FlashAlert_me
$EXEL [15s. delayed] filed SEC form 4: Director WYSZOMIERSKI JACK L: Granted 19,575 of Common Stock at price $0 on… https://t.co/YhWtVLPsr4
May 28th 2022, 12:05am
FlashAlert_me @FlashAlert_me
$EXEL [15s. delayed] filed SEC form 4: Director Garber Alan M: Transacted Derivative Securities on 2022-05-26. https://t.co/nd00jELq8a
May 28th 2022, 12:05am
FlashAlert_me @FlashAlert_me
$EXEL [15s. delayed] filed SEC form 4: Director Freire Maria C: Granted 19,575 of Common Stock at price $0 on 2022… https://t.co/3GNvHYfB4U
May 28th 2022, 12:05am
FlashAlert_me @FlashAlert_me
$EXEL [15s. delayed] filed SEC form 4: Director FELDBAUM CARL B: Granted 10,180 of Common Stock at price $0 on 202… https://t.co/EgGcAPYNu9
May 28th 2022, 12:05am
FintelAlerts @FintelAlerts
Also, if you are new to $EXEL here's a background article on Finpedia for you https://t.co/nrIRe0rJtF
May 27th 2022, 9:05pm
investor_feed @investor_feed
$EXEL 8-K Exelixis (27 May, 5:05pm) ? Departure of Directors or Certain Officers; Election of Directors… https://t.co/ueIBXS5dSP
May 27th 2022, 9:05pm
dailycandlestix @dailycandlestix
$EXEL Rising Price, Declining Volume Daily appearances since 2010: 74 Close 5 days later ±: Avg: -0.01 SD: 1.22 Wor… https://t.co/8JsQKSKjHx
May 27th 2022, 8:05pm
TradeWithAlerts @TradeWithAlerts
Nice print for $EXEL Size: 269321 Price: 18.4 Amount: $4,955,506.40 Time: 1600 See more: https://t.co/WzjaQRTmE4 Jo… https://t.co/IdqoxwITFn
May 27th 2022, 8:05pm
StockAlarms @StockAlarms
#BearishAlert Bearish Stock Alert: $EXEL at $18.24 This alert is meant for swing and day traders. For details, pl… https://t.co/x2d6WcpaeJ
May 27th 2022, 5:05pm
StockAlarms @StockAlarms
#BearishAlert Bearish Stock Alert: $EXEL at $18.20 This alert is meant for swing and day traders. For details, pl… https://t.co/H6w81mbvsE
May 27th 2022, 4:05pm
hennry48288902 @hennry48288902
Entries & exits Daily! Discord link below? https://t.co/f0Vi4YdluV $EXEL
May 27th 2022, 1:05pm
MaisaCorp @MaisaCorp
$EXEL Exelixis(EXEL) said late Thursday a phase 2 trial of cabozantinib in combination with pembrolizumab in patien… https://t.co/fnkvNSYpfX
May 26th 2022, 11:05pm
MarcJacksonLA @MarcJacksonLA
$EXEL Exelixis Announces Detailed Results from Urothelial Carcinoma and Non-Small Cell Lung Cancer Cohorts of the C… https://t.co/YyBTHliKKs
May 26th 2022, 9:05pm
otcdynamics @otcdynamics
$EXEL Exelixis Announces Detailed Results from Urothelial Carcinoma and Non-Small Cell Lung Cancer Cohorts of the C… https://t.co/2MfV3gfSsq
May 26th 2022, 9:05pm
ExelixisInc @ExelixisInc
Data from $EXEL flagship therapy in combination with an #immunotherapy in #HeadAndNeckCancer presented at #ASCO22.… https://t.co/j0Qh2GswHp
May 26th 2022, 9:05pm
otcdynamics @otcdynamics
$EXEL Exelixis Announces Results from Phase 2 Trial of Cabozantinib in Combination with Pembrolizumab in Patients w… https://t.co/cnPTZg40Bp
May 26th 2022, 9:05pm
ExelixisInc @ExelixisInc
Positive results from studies of $EXEL flagship therapy and @Roche #immunotherapy in #BladderCancer and #LungCancer… https://t.co/RFNE2l1yHk
May 26th 2022, 9:05pm
StockNewsBot2 @StockNewsBot2
$EXEL Exelixis Announces Detailed Results from Urothelial Carcinoma and Non-Small Cell Lung Cancer Cohorts of the C… https://t.co/RINcfZ7Sn1
May 26th 2022, 9:05pm
StockNewsBot2 @StockNewsBot2
$EXEL Exelixis Announces Results from Phase 2 Trial of Cabozantinib in Combination with Pembrolizumab in Patients w… https://t.co/npa7geo9y0
May 26th 2022, 9:05pm
FastestAlert @FastestAlert
$EXEL Exelixis Announces Detailed Results From Urothelial Carcinoma And Non-Small Cell Lung Cancer Cohorts Of The C… https://t.co/CgCbKT6SpF
May 26th 2022, 9:05pm
FastestAlert @FastestAlert
$EXEL Exelixis Announces Results From Phase 2 Trial Of Cabozantinib In Combination With Pembrolizumab In Patients W… https://t.co/Nz7ght2qlC
May 26th 2022, 9:05pm
stock_titan @stock_titan
$EXEL Exelixis Announces Detailed Results from Urothelial Carcinoma and Non-Small Cell Lung Cancer Cohorts of the C… https://t.co/uhQjHRqfpt
May 26th 2022, 9:05pm
stock_titan @stock_titan
$EXEL Exelixis Announces Results from Phase 2 Trial of Cabozantinib in Combination with Pembrolizumab in Patients w… https://t.co/6pFOWJ7lSw
May 26th 2022, 9:05pm
Thomas08127907 @Thomas08127907
Entries & exits Daily! Discord link below? https://t.co/xZlWpQd5y4 $EXEL
May 26th 2022, 8:05pm
james73264347 @james73264347
.??. Alerts ? .??. Update ?? .??. Watchlist,?? .??. Discord link below ?? ? ? .*. https://t.co/LIQGUJ7HIG $EXEL
May 26th 2022, 8:05pm
paul12916846 @paul12916846
Entries & exits Daily! Discord link below? https://t.co/NjgmbzuDtU $EXEL
May 26th 2022, 8:05pm
StockAlarms @StockAlarms
#BearishAlert Bearish Stock Alert: $EXEL at $18.29 This alert is meant for swing and day traders. For details, pl… https://t.co/2q9hKZUiBR
May 26th 2022, 7:05pm
hennry48288902 @hennry48288902
Entries & exits Daily! Discord link below? https://t.co/f0Vi4YdluV $EXEL
May 26th 2022, 6:05pm
datadili @datadili
Exelixis, Inc. traded 121% above average volume, $EXEL closed up 0.62%
May 26th 2022, 2:05am
Daniel21911478 @Daniel21911478
Alerts. ? Update ?? Watchlist,?? Discord link below ?? ? ? https://t.co/zgikneiovX $EXEL
May 25th 2022, 6:05pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.